Guide · 7 min · 2026-07-23
Multi-plant document control without seat sprawl
How pharmaceutical groups scale controlled documents across plants when per-user and per-site fees punish growth—and what to demand in a commercial model.
Growth should not renegotiate every login
When a second plant or a wave of contractors arrives, seat taxes and plant fees turn quality expansion into a budget crisis. Model five years of users and sites before you shortlist.
One identity story across sites
Multi-plant groups need shared governance with clear site segregation—not a separate directory and license pile for every location. Ask how roles and plants are modeled in one platform.
Effective documents still matter locally
Corporate templates help, but floors need the right effective version for their site. Controlled print and training awareness should survive multi-plant complexity.
What good commercial models look like
Prefer unlimited users and plants in the standard model so collaboration is not rationed. Compare AMC bands honestly—relative positioning beats brochure numbers.
Novaqis posture
Unlimited users and manufacturing sites in the standard commercial model. See Value & TCO, India pharma, and For manufacturing for the buyer story—contact us for a tailored quote.
Ready to see Novaqis on your terms?
We prefer live walkthroughs over generic slides. Ask for a demo or a tailored quote—no published list prices.